One in ten people has respiratory problems such as asthma, chronic bronchitis and cystic fibrosis. A Stockholm-based startup has stepped up to improve the lives of people suffering from these conditions. NuvoAir combines hardware, software and data to make respiratory diseases measurable and more treatable.

Lorenzo Consoli founded NuvoAir in 2015. The startup was originally called Pond Healthcare Innovation but was rebranded to NuvoAir in the summer of 2017. The company decided to rebrand as a testament to its focus on respiratory care and solutions.

NuvoAir first released Air Smart Spirometer which helps patients understand how their lung health changes over time. Additionally, it allows the patients to connect results seamlessly with their physicians. The product was launched in Europe in 2016. It was undoubtedly very successful in the market, with thousands of units sold among physicians and patients in over 20 countries. 

Later, the startup invented Air Next Spirometer, the first spirometer that can connect to a smartphone. The portable home-use spirometer device allows to people assess their lung health in seconds, anytime, anywhere. It measures all of the same parameters which are recorded by medical professionals. Moreover, Air Next costs a fraction of the price of standard spirometers found in hospitals and clinics.

It also developed Aria, a digital therapeutics software which sends patients personalized care suggestions based on their condition.

In 2017, NuvoAir received 2 million Euros in seed capital from Investment AB Spiltan, a leading Venture Fund in the Nordics. In total it has raised $5.2 million in funding over 2 rounds. There are others in the healthcare field. Notably, Propeller Health, which is known for its connected inhaler. ResMed acquired Propeller Health in early 2019 for $225 million.